These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6503891)

  • 1. Effects of 25-OHD3 on renal function in pediatric patients with chronic renal failure.
    Mazur AT; Norman ME
    Miner Electrolyte Metab; 1984; 10(6):351-8. PubMed ID: 6503891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure.
    Chan JC; Kodroff MB; Landwehr DM
    Pediatrics; 1981 Oct; 68(4):559-71. PubMed ID: 6895662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,25(OH)2D3 and 25-OHD3 in the treatment of renal osteodystrophy: comparison of combined versus 1,25(OH)2D3 administration alone.
    Coen G; Taccone Gallucci M; Bonucci E; Ballanti P; Bianchi AR; Bianchini G; Matteucci MC; Mazzaferro S; Picca S; Taggi F; Cinotti GA; Casciani CU
    Miner Electrolyte Metab; 1983; 9(1):19-27. PubMed ID: 6687749
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of low dose 1 alpha-hydroxycholecalciferol on glomerular filtration rate in moderate renal failure.
    Eke FU; Winterborn MH
    Arch Dis Child; 1983 Oct; 58(10):810-3. PubMed ID: 6357106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal osteodystrophy in early chronic renal failure.
    Suzuki M; Hirasawa Y
    Contrib Nephrol; 1980; 22():28-38. PubMed ID: 7398337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renal osteodystrophy in two children : a comparison of the effects of 1 alpha-hydroxycholecalciferol (author's transl)].
    Chantraine JM; Davin JC; Lambrechts L; Heynen G
    Ann Endocrinol (Paris); 1979; 40(2):161-2. PubMed ID: 475307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal osteodystrophy in children with end-stage kidney failure.
    Chan JC
    Va Med; 1979 May; 106(5):384-90. PubMed ID: 463255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-alpha-hydroxyvitamin D3 in chronic renal failure. A potent analogue of the kidney hormone, 1,25-dihydroxycholecalciferol.
    Chan JC; Oldham SB; Holick MF; DeLuca HF
    JAMA; 1975 Oct; 234(1):47-52. PubMed ID: 1174223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal osteodystrophy and growth in children undergoing CAPD].
    Ito T; Horiike S; Iitaka K
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):779-90. PubMed ID: 1770638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypohyperparathyroidism: a model for renal osteodystrophy?
    Junor BJ; Edward N
    Postgrad Med J; 1981 Jun; 57(668):371-7. PubMed ID: 7301683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Letter to the authors of the "Recommendations for clinical practice" concerning the prevention of renal osteodystrophy before extra-renal purification].
    Fournier A; Aparicio M
    Nephrologie; 1998; 19(3):129-30. PubMed ID: 9633056
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3.
    Madsen S
    Acta Med Scand Suppl; 1980; 638():3-120. PubMed ID: 6929650
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal osteodystrophy in children with chronic renal failure: an unexpectedly common and incapactating complication.
    Hsu AC; Kooh SW; Fraser D; Cumming WA; Fornasier VL
    Pediatrics; 1982 Nov; 70(5):742-50. PubMed ID: 6982452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone modulating factors in nephrotic children with normal glomerular filtration rate.
    Freundlich M; Bourgoignie JJ; Zilleruelo G; Jacob AI; Canterbury JM; Strauss J
    Pediatrics; 1985 Aug; 76(2):280-5. PubMed ID: 3839579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium and phosphorus in diet therapy of uremia.
    Schoolwerth AC; Engle JE
    J Am Diet Assoc; 1975 May; 66(5):460-4. PubMed ID: 1123506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-alpha-OH-cholecalciferol (1-alpha-OHD3) and low phosphate diet in predialysis chronic renal failure: effects on renal function and on secondary hyperparathyroidism.
    Coen G; Messa F; Massimetti C; Mazzaferro S; Manganiello M; Donato G; Finistauri D; Giuliano G; Cinotti GA
    Acta Vitaminol Enzymol; 1984; 6(2):129-35. PubMed ID: 6496255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal osteodystrophy in children with chronic renal insufficiency].
    Furková K; Sasinka M; Kaiserová E; Suchánek A
    Cesk Pediatr; 1986 Sep; 41(9):514-8. PubMed ID: 3769023
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of vitamin D metabolites on indicators of protein, phosphorus and calcium metabolism in children with chronic renal failure].
    Denisova SN; Kutafina EK; Sergeeva TV; Savina MI; Kon' IIa; Shilina NM; Chizhevskaia OL; Shilov AV
    Vopr Pitan; 1999; 68(5-6):35-40. PubMed ID: 10641280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term effects of a combination of 25-hydroxycholecalciferol and 1-alpha-hydroxycholecalciferol on osteodystrophy in chronic hemodialysis patients].
    Sebert JL; Marie A; Kuntz D; Marie P; Gueris J; Smadja A; Fournier A; Quichaud J
    Rev Rhum Mal Osteoartic; 1981; 48(7-9):535-41. PubMed ID: 7291931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of renal osteodystrophy.
    Baker LR
    Miner Electrolyte Metab; 1991; 17(4):240-9. PubMed ID: 1813786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.